Search
for
Sort by
Research 631–660 of 643
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Hirsutism and Health Related Quality of Life
- Advances in Stem Cell Therapy: Specific Applications in the Treatment of Cutaneous Radiation Syndrome
- LAM/TSC Cell Migration to Uterus in an Experimental Model of Lymphangioleiomyomatosis. Regulation by Anti-Epidermal Growth Factor Receptor Antibody and Rapamycin
- Clinical Efficacy and Safety of Baricitinib in Patients With Alopecia Areata in Korea
- Analysis of changes in microRNA expression profiles in response to the troxerutin-mediated antioxidant effect in human dermal papilla cells
- Inflammation in androgenetic alopecia and hair loss: linking neurosciences-endocrinology-dermatology
- Evaluation of the Hemogram of Breast Cancer Patients Treated by Therapeutic Protocol Based on Immunohistochemical Analysis: A Retrospective Study
- Follicular unit extraction method of hair transplantation: Technique, advantages and limitations
- 3D spheroid culture synchronizes heterogeneous MSCs into an immunomodulatory phenotype with enhanced anti-inflammatory effects
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- Skin, mucosa and nail findings in hospitalized pediatric patients with Coronavirus disease-2019 (COVID-19)
- The Dermatological Spectrum of Coronavirus Disease-19 Disease: Cutaneous Signs for Diagnostics and Prognosis and an Expanded Classification
- The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case–control analysis using German claims data
- Glucocorticoids and Risk of Venous Thromboembolism in Asthma Patients Aged 20–59 Years in the United Kingdom’s CPRD 1995–2015
- PD49-03 IS TADALAFIL ASSOCIATED WITH DECREASED RISK OF MAJOR ADVERSE CARDIAC EVENTS OR VENOUS THROMBOEMBOLISM IN MEN WITH LOWER URINARY TRACT SYMPTOMS?
- Alopecia areata does not increase the risk of venous thromboembolism: an All of Us case-control study
- Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician Survey
- Association of Surgical Risk With Exogenous Hormone Use in Transgender Patients
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Family planning 2011: better use of existing methods, new strategies and more informed choices for female contraception
- Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia
- Hormonal contraceptives: pharmacology tailored to women's health
- Transgender health and the impact of aging and menopause
- Gonadal Suppressive and Cross‐Sex Hormone Therapy for Gender Dysphoria in Adolescents and Adults
- Combined hormonal contraception and venous thromboembolism
- Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis
- 52309 Association of venous thromboembolism in patients with alopecia areata